J9206
J9206 – Injection, irinotecan, 20 mg · NDC Crosswalk & Billing Units
HCPCS Level II J-code · Medicare Part B drug billing
J-code
● 43 NDCs crosswalked per 20 MG $1.851/unit ASP+6%
📋 J9206 summary
J9206 is a HCPCS Level II J-code used to bill irinotecan, 20 mg, billed per 20 MG. The number of billing units to report depends on the dose administered and the NDC/package billed — use the calculator below.
Brand names associated with J9206: Camptosar*, Camptosar, Irinotecan Hydrochloride
Code J9206
Billing unit 20 MG Payment limit $1.851/unit NDC-Crosswalk 43
Quarter Q3 2026
RxCUI Atlas Trace the drug concept →
⚠ An NDC↔HCPCS crosswalk and a published payment limit do not guarantee payer coverage or payment. Always verify the current payer policy and claim format before billing.
🗂️ Key billing facts
HCPCS codeJ9206
DescriptorInjection, irinotecan, 20 mg
Billing unit20 MG
Payment limit / unit$1.851
Est. ASP / unit$1.746 est.
Mapped NDCs43
Data periodQ3 2026
Last updated2026-08-20
💊 About Irinotecan Injection DRUG GUIDE
Irinotecan Hydrochloride Injection is used to treat metastatic carcinoma of the colon or rectum (colorectal cancer that has spread).
It is approved for use in combination with 5-fluorouracil (5-FU) and leucovorin as a first-line (initial) treatment option.It is also used as a treatment for patients whose colorectal cancer has come back or continued to grow after prior fluorouracil-based chemotherapy — either in combination with other drugs or as a single agent.
Clinical overview from our editorial drug guide for Irinotecan Injection. For billing reference, see the sections above.
🧾 Billing & reimbursement HCPCS · CMS · EFF. Q3 2026
📅 Payment limits effective Q3 2026 — from the CMS Medicare Part B Payment Limit File (revised quarterly).
Medicare payment limit / unit
$1.851
Est. ASP / unit
$1.746 est.
Est. after 2% sequester
$1.814
HCPCS dosage
20 MG
The CMS payment limit is the Medicare Part B drug allowance (ASP + 6%, statutory). After the 2% federal sequester the effective payment is ≈ ASP + 4.3%; estimated ASP = payment limit ÷ 1.06. Source: CMS Medicare Part B Payment Limit File (quarterly), Q3 2026.
Full HCPCS code details (official CMS record)
Long descriptionInjection, irinotecan, 20 mg
CoverageD — Special coverage instructions apply
Pricing indicator51 — Drug — priced under the ASP methodology
Type of service1 — Medical care
BETOS-2O1D
ASC payment group—
Action codeN — No maintenance this year
Effective date2009-01-01
Date added1998-01-01
Source: CMS HCPCS Level II code file (imported via admin).
🧮 Dosing & billing-units calculator HCPCS UNITS
One billing unit of J9206 = 20 mg. Enter a regimen to convert dose → billing units and project a full course.
Billing units = dose ÷ HCPCS unit size. Most payers require whole units — round per the payer's policy. “Est. Medicare pay” uses the current payment limit. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (JZ when none is discarded) where allowed. Always verify payer-specific rounding before billing.
🔁 NDCs that bill under J9206 WITH EST. MEDICARE PAY
43 NDCs map to J9206. Bill units = how many HCPCS units one package represents. Est. pay / pkg = payment limit ($1.851/unit) × that package's bill units.
| NDC (11-digit) | Drug | Labeler | Package | Strength | Bill units | Est. pay / pkg | NADAC / unit | Status | Source |
|---|---|---|---|---|---|---|---|---|---|
| 00009-0082-02 | Camptosar irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Pharmacia | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0082... | 20 mg/mL | 15 | $27.77 | — | ● Active | CMS + PDAC |
| 00009-0112-05 | Camptosar irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Pharmacia | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-0112... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 00009-7529-03 | Camptosar | Pfizer | — | — | 5 | $9.26 | — | — | CMS ASP |
| 00009-7529-04 | Camptosar | Pfizer | — | — | 2 | $3.70 | — | — | CMS ASP |
| 00009-7529-05 | Camptosar irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Pharmacia | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529... | 20 mg/mL | 15 | $27.77 | — | ● Active | CMS ASP |
| 00009-7529-10 | Camptosar irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Pharmacia | 1 VIAL, SINGLE-DOSE in 1 CARTON (0009-7529... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 00143-9701-01 | Irinotecan Hydrochloride 20 mg/mL INJECTION | Hikma | 5 mL in 1 VIAL, GLASS (0143-9701-01) | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS ASP |
| 00143-9702-01 | Irinotecan Hydrochloride 20 mg/mL INJECTION | Hikma | 2 mL in 1 VIAL, GLASS (0143-9702-01) | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS ASP |
| 16714-0027-01 | Irinotecan hydrochloride 20 mg/mL INJECTION | Northstar | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-027... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 16714-0131-01 | Irinotecan hydrochloride 20 mg/mL INJECTION | Northstar | 1 VIAL, SINGLE-DOSE in 1 CARTON (16714-131... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 25021-0230-02 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-230-02) / 2 mL... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 25021-0230-05 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Sagent | 1 VIAL in 1 CARTON (25021-230-05) / 5 mL... | 20 mg/mL | 5 | $9.26 | — | Obsolete | CMS + PDAC |
| 45963-0614-51 | Irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Actavis | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 45963-0614-55 | Irinotecan hydrochloride 20 mg/mL INJECTION, SOLUTION | Actavis | 1 VIAL, SINGLE-DOSE in 1 CARTON (45963-614... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 50742-0401-02 | Irinotecan Hydrochloride 40 mg/2mL INJECTION | Ingenus | 1 VIAL, GLASS in 1 CARTON (50742-401-02)... | 40 mg/2mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 50742-0402-05 | Irinotecan Hydrochloride 100 mg/5mL INJECTION | Ingenus | 1 VIAL, GLASS in 1 CARTON (50742-402-05)... | 100 mg/5mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 55150-0352-01 | IRINOTECAN HYDROCHLORIDE 20 mg/mL INJECTION, SOLUTION | Eugia | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-352... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 55150-0353-01 | IRINOTECAN HYDROCHLORIDE 20 mg/mL INJECTION, SOLUTION | Eugia | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-353... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 55150-0354-01 | IRINOTECAN HYDROCHLORIDE 20 mg/mL INJECTION, SOLUTION | Eugia | 1 VIAL, SINGLE-DOSE in 1 CARTON (55150-354... | 20 mg/mL | 15 | $27.77 | — | ● Active | CMS + PDAC |
| 60505-6128-00 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Apotex | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 60505-6128-01 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Apotex | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6128... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 60505-6272-01 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Apotex | 1 VIAL, SINGLE-USE in 1 CARTON (60505-6272... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 61703-0349-09 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 61703-0349-16 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 61703-0349-36 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Hospira, | 1 VIAL, SINGLE-DOSE in 1 CARTON (61703-349... | 20 mg/mL | 25 | $46.28 | — | ● Active | CMS + PDAC |
| 63323-0193-52 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Fresenius | 1 VIAL in 1 BOX (63323-193-52) / 2 mL in... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS ASP |
| 63323-0193-55 | Irinotecan Hydrochloride 20 mg/mL INJECTION, SOLUTION | Fresenius | 1 VIAL in 1 BOX (63323-193-55) / 5 mL in... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS ASP |
| 68001-0480-22 | Irinotecan hydrochloide 20 mg/mL INJECTION | BluePoint | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 68001-0480-35 | Irinotecan hydrochloide 20 mg/mL INJECTION | BluePoint | 1 VIAL, SINGLE-DOSE in 1 CARTON (68001-480... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 70700-0169-22 | Irinotecan hydrochloide 20 mg/mL INJECTION | Xiromed | 1 VIAL, SINGLE-DOSE in 1 CARTON (70700-169... | 20 mg/mL | 2 | $3.70 | — | ● Active | CMS + PDAC |
| 70700-0170-22 | Irinotecan hydrochloride 20 mg/mL INJECTION | Xiromed | 1 VIAL, SINGLE-DOSE in 1 CARTON (70700-170... | 20 mg/mL | 5 | $9.26 | — | ● Active | CMS + PDAC |
| 72485-0213-15 | IRINOTECAN HYDROCHLORIDE (1X15ML;SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 72485-0212-05 | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 72485-0211-02 | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 59923-0716-15 | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 59923-0715-05 | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 59923-0714-02 | IRINOTECAN HYDROCHLORIDE (SDV) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 45963-0614-81 | PREMIERPRO RX IRINOTECAN HCL (PF,LATEX-FREE) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 45963-0614-85 | PREMIERPRO RX IRINOTECAN HCL (PF,LATEX-FREE) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 16714-0726-01 | IRINOTECAN HYDROCHLORIDE (SDV,PF,LATEX-FREE) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 16714-0725-01 | IRINOTECAN HYDROCHLORIDE (SDV,PF,LATEX-FREE) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 68001-0284-25 | IRINOTECAN HYDROCHLORIDE (1X5ML,SINGLE DOSE,PF) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
| 68001-0284-34 | IRINOTECAN HYDROCHLORIDE (PF,LATEX-FREE) 20 MG/1 ML | Unknown | — | — | 1 | $1.85 | — | — | PDAC |
NDC→HCPCS mappings come from the CMS ASP NDC-HCPCS crosswalk; additional DME MAC / DMEPOS mappings come from PDAC and are labeled separately. NADAC from CMS (weekly). “Status” reflects the product's marketing / obsolete flag in the NDC directory. Presence or absence here does not determine Medicare coverage. Linked NDCs open the full product page.
📊 Medicare utilization & spend CMS · PART B · 2026 (Q1)
Period
Total Part B spend
$245.5K
Claims
10,330
Beneficiaries
3,110
Spend / beneficiary
$78.94
Spend / claim
$23.77
Trend by period
Where J9206 ranks among Part B drugs · 2026 (Q1) · neighbors ±5
Total spending — #509 of 824
#504
GADOTERIDOL* A9579
$262K
#505
BEIZRAY-ALBUMIN* J9174
$258.2K
#506
CYCLOPHOSPHAMIDE(J90... J9071
$255.9K
#507
ERTAPENEM J1335
$254.7K
#508
SURGRAFT TL, PER SQ... Q4263
$246.1K
#509
CAMPTOSAR* J9206
$245.5K
#510
EPIEFFECT, PER SQ CM... Q4278
$240.8K
#511
CEFTRIAXONE J0696
$239.8K
#512
KHAPZORY J0642
$235.8K
#513
CYCLOPHOSPHAMIDE(J85... J8530
$233.2K
#514
LEUKINE J2820
$227.5K
Total claims — #162 of 824
#157
AKYNZEO J1454
11,028
#158
RUXIENCE Q5119
11,016
#159
RAPAMUNE* J7520
10,934
#160
GADOTERIDOL* A9579
10,762
#161
LIBTAYO J9119
10,576
#162
CAMPTOSAR* J9206
10,330
#163
ZARXIO Q5101
10,231
#164
CUBICIN RF* J0878
9,691
#165
TRIESENCE J3300
9,687
#166
CYCLOSPORINE MODIFIE... J7515
9,668
#167
FOCINVEZ J1434
9,640
Top Medicare Part B drugs by the selected metric. Click any drug to open its J-code page. Source: CMS Medicare Quarterly Part B Spending by Drug.
Full breakdown by period (2)
| Period | Total spend | Beneficiaries | Claims | $/beneficiary | $/claim |
|---|---|---|---|---|---|
| 2026 (Q1) | $245.5K | 3,110 | 10,330 | $78.94 | $23.77 |
| 2025 (Q1-Q4) | $974.6K | 6,486 | 43,307 | $150.26 | $22.50 |
Provider-administered (Part B) spend, calculated for the whole HCPCS code (CMS does not publish Medicare spend per individual NDC). Self-administered use is covered under Part D instead. A blank patient count means fewer than 11 people — CMS hides counts that small to protect privacy. Source: CMS Medicare Quarterly Part B Spending by Drug (data.cms.gov), updated quarterly.
📈 Medicare Part B claims detail CMS PSPS · 2024
Calendar-year 2024 Medicare Part B fee-for-service activity for this HCPCS code, summed across all carriers, localities and specialties (CMS Physician/Supplier Procedure Summary). A “service” is one billed line/unit — not one claim — so counts run higher than claim counts.
Allowed charges
$995.7K
Medicare paid
$768.7K
Submitted services
629,395
Denial rate
5.8%
Allowed / service
$1.68
Submitted charges
$68.36M
Source: CMS Physician/Supplier Procedure Summary (PSPS), CY2024 — Medicare Part B carrier + DME fee-for-service claims (excludes Medicare Advantage). Figures are for the whole HCPCS code, which may cover uses beyond this drug. ⚠ CMS hides any figure covering fewer than 11 patients (a privacy rule), so totals — especially denials and low-volume codes — run a little low.
🗺️ Where J9206 is utilized CMS · BY PROVIDER · 2024
Medicare Part B services for this code by the rendering provider's state — 88,367 services across 28 states & territories in 2024 (CMS reports include DC and U.S. territories). Switch to per 100k to compare states fairly regardless of population. Hover or tap a state for its top ZIP codes.
Hover or tap a state to see its numbers + top ZIP codes.
Per-capita = services ÷ 2023 state population × 100,000 (so high-population states aren't automatically "hotter"). Counts reflect the provider's location, not the patient's. Providers with fewer than 11 patients are hidden by CMS for privacy, so totals run low and per-100k can be noisy in small states — read this as relative geography, not exact counts. Source: CMS Medicare Physician & Other Practitioners — by Provider and Service, 2024.
📊 What bills under J9206
J-codes are billing codes often used for drugs billed under the medical benefit. This connects the billing code to the NDC package records it covers, by ingredient and labeler.
NDC products by ingredient
NDC products by labeler
🗃️ Data sources & freshness
Every figure on this page is computed from public datasets. Here's what each section draws on and how current it is.
HCPCS code & descriptor
CMS HCPCS Level II code file
Loaded
Payment limit & billing unit
CMS Medicare Part B ASP Pricing File (quarterly)
Q3 2026 · as of 2026-08-20
NDC ↔ HCPCS crosswalk
CMS ASP NDC-HCPCS crosswalk + DMEPDAC (PDAC)
43 NDCs mapped
NADAC acquisition cost
CMS National Average Drug Acquisition Cost (weekly)
Not available for mapped NDCs
Utilization & spend
CMS Part B Spending by Drug · PSPS · Physician & Other Practitioners
Latest data year 2026
Figures are estimates for reference and may lag the source files. Always verify against the current CMS files and your payer's policy before submitting claims.
⚠️ Practical billing caveats
- A crosswalk is not coverage. An NDC mapping or a published payment limit does not guarantee a payer will cover or pay this code. Check the specific plan's policy.
- Units ≠ milligrams. Bill the number of HCPCS units (dose ÷ the code's unit size), not the milligram dose. Use the calculator above.
- Discarded drug. For single-dose vials, drug discarded after administration may be separately billable with modifier JW (and JZ when nothing is discarded) where the payer allows.
- Rounding & partial units. Many payers require whole units; round per the payer's policy, not automatically up.
- The code can cover more than this drug. Some HCPCS codes span multiple products or strengths — confirm the exact code for the product administered.
- Figures lag. ASP limits change quarterly and utilization data are released with a delay. Verify against the current CMS files before billing.
❓ J9206 billing FAQ
What is HCPCS code J9206?
J9206 is a HCPCS Level II J-code used to bill Injection, irinotecan, 20 mg under Medicare Part B and most medical (not pharmacy) benefits.
What is the billing unit for J9206?
One unit of J9206 represents 20 MG. Report the number of units equal to the dose administered divided by 20 MG.
How many units of J9206 should I bill?
Divide the dose administered by the code's unit size (20 MG) to get the number of billing units, then round per your payer's policy. The calculator on this page converts a dose into billing units and projects a full course.
How much does Medicare pay for J9206?
The Medicare Part B payment limit is $1.851 per unit (Q3 2026), based on ASP + 6%. After the 2% sequester the effective payment is about $1.814 per unit. Payment limits are revised quarterly.
Which NDCs bill under J9206?
43 NDCs currently map to J9206 in the CMS ASP NDC-HCPCS crosswalk. See the NDC crosswalk table above for each product, package, billing units and estimated reimbursement.
Does a crosswalk mean J9206 is covered?
No. An NDC-to-HCPCS crosswalk and a published payment limit do not guarantee coverage or payment. Coverage depends on the payer, the diagnosis and the site of care — always verify the current policy before billing.
For professional billing reference only — verify against the current CMS files before submitting claims.